Back to Search Start Over

Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity.

Authors :
Ferlazzo GM
Gambetta AM
Amato S
Cannizzaro N
Angiolillo S
Arboit M
Diamante L
Carbognin E
Romani P
La Torre F
Galimberti E
Pflug F
Luoni M
Giannelli S
Pepe G
Capocci L
Di Pardo A
Vanzani P
Zennaro L
Broccoli V
Leeb M
Moro E
Maglione V
Martello G
Source :
Nature communications [Nat Commun] 2023 Jul 05; Vol. 14 (1), pp. 3962. Date of Electronic Publication: 2023 Jul 05.
Publication Year :
2023

Abstract

Huntington's disease (HD) is a neurodegenerative disorder caused by CAG-repeat expansions in the huntingtin (HTT) gene. The resulting mutant HTT (mHTT) protein induces toxicity and cell death via multiple mechanisms and no effective therapy is available. Here, we employ a genome-wide screening in pluripotent mouse embryonic stem cells (ESCs) to identify suppressors of mHTT toxicity. Among the identified suppressors, linked to HD-associated processes, we focus on Metal response element binding transcription factor 1 (Mtf1). Forced expression of Mtf1 counteracts cell death and oxidative stress caused by mHTT in mouse ESCs and in human neuronal precursor cells. In zebrafish, Mtf1 reduces malformations and apoptosis induced by mHTT. In R6/2 mice, Mtf1 ablates motor defects and reduces mHTT aggregates and oxidative stress. Our screening strategy enables a quick in vitro identification of promising suppressor genes and their validation in vivo, and it can be applied to other monogenic diseases.<br /> (© 2023. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
14
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
37407555
Full Text :
https://doi.org/10.1038/s41467-023-39552-9